James Davison - Concepedia

Author

James Davison

Also Known As

Davison J, J Davison, J. Davison, J. E. Davison, J.E. Davison, James Davison, James Davison, James E Davison, James E. Davison, James M. Davison

121

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University College London Great Ormond Street Hospital for Children NHS Foundation Trust Great Ormond Street Hospital National Hospital for Neurology and Neurosurgery Birmingham Children's Hospital

About

James Davison is an author at University College London specializing in medicine, pathology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	182
2	Business	1	1	116
3	Education	1	1	116
4	Management	1	1	116
5	Public Health	1	1	34

James Davison

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy Marc Engelen, Wouter J. C. van Ballegoij, Eric J. Mallack, Neurology	2022	128
Recessive germline <i>SDHA</i> and <i>SDHB</i> mutations causing leukodystrophy and isolated mitochondrial complex II deficiency Charlotte L. Alston, James Davison, Francesca Meloni, Journal of Medical Genetics	2012	122
How Leaders Can Influence the Impact That Stressors Have on Soldiers Thomas W. Britt, James Davison, Paul D. Bliese, Military Medicine Military ContextWrair ProgramEducationMilitary SociologyHuman Resource Management	2004	116
Response of 33 UK patients with infantile‐onset Pompe disease to enzyme replacement therapy Alexander Broomfield, Joan Fletcher, James Davison, Journal of Inherited Metabolic Disease	2015	70
Expanding the phenotype in argininosuccinic aciduria: need for new therapies Julien Baruteau, Elisabeth Jameson, Andrew A. M. Morris, Journal of Inherited Metabolic Disease	2017	70
Intellectual and neurological functioning in Morquio syndrome (MPS IVa) James Davison, Shauna Kearney, Johan Horton, Journal of Inherited Metabolic Disease	2012	51
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis report Priya S. Kishnani, David Kronn, Anaïs Brassier, Genetics in Medicine	2022	51
Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England Alexander Broomfield, James Davison, Joseph Roberts, Molecular Genetics and Metabolism Enzyme Replacement TherapyPediatricsPathologyMedicineLysosomal Storage Disease	2019	49
Successful reversal of propionic acidaemia associated cardiomyopathy: Evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism Julien Baruteau, Iain P. Hargreaves, S. Krywawych, Mitochondrion Cardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseMitochondrial Function	2014	48
MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation James Davison, Nigel P. Davies, Martin Wilson, Orphanet Journal of Rare Diseases	2011	41

Page 1